WO1992003412A3 - Derives de benzamide - Google Patents
Derives de benzamide Download PDFInfo
- Publication number
- WO1992003412A3 WO1992003412A3 PCT/GB1991/001375 GB9101375W WO9203412A3 WO 1992003412 A3 WO1992003412 A3 WO 1992003412A3 GB 9101375 W GB9101375 W GB 9101375W WO 9203412 A3 WO9203412 A3 WO 9203412A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carbon
- alkyl
- groups
- optionally
- sulphinyl
- Prior art date
Links
- 150000003936 benzamides Chemical class 0.000 title abstract 2
- -1 sulphinyl Chemical group 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 abstract 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 3
- 125000005842 heteroatom Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/49—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/42—Y being a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9017711.4 | 1990-08-13 | ||
| GB909017711A GB9017711D0 (en) | 1990-08-13 | 1990-08-13 | New compositions of matter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1992003412A2 WO1992003412A2 (fr) | 1992-03-05 |
| WO1992003412A3 true WO1992003412A3 (fr) | 1992-04-30 |
Family
ID=10680576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB1991/001375 WO1992003412A2 (fr) | 1990-08-13 | 1991-08-13 | Derives de benzamide |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0543865A1 (fr) |
| JP (1) | JPH06500315A (fr) |
| AU (1) | AU8427591A (fr) |
| CA (1) | CA2089151A1 (fr) |
| GB (1) | GB9017711D0 (fr) |
| IE (1) | IE912848A1 (fr) |
| IL (1) | IL99159A0 (fr) |
| PT (1) | PT98666A (fr) |
| WO (1) | WO1992003412A2 (fr) |
| ZA (1) | ZA916338B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2894445B2 (ja) | 1997-02-12 | 1999-05-24 | 日本たばこ産業株式会社 | Cetp活性阻害剤として有効な化合物 |
| WO2004082675A1 (fr) | 2003-03-17 | 2004-09-30 | Japan Tobacco Inc. | Procede pour accroitre la biodisponibilite orale de s- [2- ([[1- (2-ethylbutyl) cyclohexyl] carbonyl] amino) phenyl] -2-methylpropanethioate |
| EP3441382B1 (fr) * | 2016-04-05 | 2023-08-30 | Moresco Corporation | Composé d'oxa-acide |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2476074A1 (fr) * | 1979-12-13 | 1981-08-21 | Lilly Co Eli | Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques |
| EP0077534A2 (fr) * | 1981-10-15 | 1983-04-27 | Chugai Seiyaku Kabushiki Kaisha | Dérivés benzamide, procédé pour leur préparation et compositions pharmaceutiques les contenant |
| US4536346A (en) * | 1983-05-06 | 1985-08-20 | American Cyanamid Company | Aralkanamidophenyl compounds |
| WO1986003199A1 (fr) * | 1984-11-29 | 1986-06-05 | Italfarmaco S.P.A. | Derives de l'acide amino-salicylique et compositions pharmaceutiques |
| EP0195582A1 (fr) * | 1985-03-14 | 1986-09-24 | SMITH KLINE DAUELSBERG GmbH | Derivés de l'acide Amino-5 salicylique d'acide anti-inflammatoires non-steroiques |
| EP0318859A2 (fr) * | 1987-12-03 | 1989-06-07 | Dainippon Pharmaceutical Co., Ltd. | Dérivés N-substitués de mercaptopropionamide |
-
1990
- 1990-08-13 GB GB909017711A patent/GB9017711D0/en active Pending
-
1991
- 1991-08-12 IE IE284891A patent/IE912848A1/en unknown
- 1991-08-12 ZA ZA916338A patent/ZA916338B/xx unknown
- 1991-08-12 IL IL99159A patent/IL99159A0/xx unknown
- 1991-08-13 WO PCT/GB1991/001375 patent/WO1992003412A2/fr not_active Application Discontinuation
- 1991-08-13 EP EP91914392A patent/EP0543865A1/fr not_active Withdrawn
- 1991-08-13 PT PT98666A patent/PT98666A/pt not_active Application Discontinuation
- 1991-08-13 AU AU84275/91A patent/AU8427591A/en not_active Abandoned
- 1991-08-13 JP JP3513671A patent/JPH06500315A/ja active Pending
- 1991-08-13 CA CA002089151A patent/CA2089151A1/fr not_active Abandoned
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2476074A1 (fr) * | 1979-12-13 | 1981-08-21 | Lilly Co Eli | Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques |
| EP0077534A2 (fr) * | 1981-10-15 | 1983-04-27 | Chugai Seiyaku Kabushiki Kaisha | Dérivés benzamide, procédé pour leur préparation et compositions pharmaceutiques les contenant |
| US4536346A (en) * | 1983-05-06 | 1985-08-20 | American Cyanamid Company | Aralkanamidophenyl compounds |
| WO1986003199A1 (fr) * | 1984-11-29 | 1986-06-05 | Italfarmaco S.P.A. | Derives de l'acide amino-salicylique et compositions pharmaceutiques |
| EP0195582A1 (fr) * | 1985-03-14 | 1986-09-24 | SMITH KLINE DAUELSBERG GmbH | Derivés de l'acide Amino-5 salicylique d'acide anti-inflammatoires non-steroiques |
| EP0318859A2 (fr) * | 1987-12-03 | 1989-06-07 | Dainippon Pharmaceutical Co., Ltd. | Dérivés N-substitués de mercaptopropionamide |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0543865A1 (fr) | 1993-06-02 |
| GB9017711D0 (en) | 1990-09-26 |
| CA2089151A1 (fr) | 1992-02-14 |
| PT98666A (pt) | 1992-06-30 |
| IE912848A1 (en) | 1992-02-26 |
| IL99159A0 (en) | 1992-07-15 |
| JPH06500315A (ja) | 1994-01-13 |
| ZA916338B (en) | 1992-05-27 |
| AU8427591A (en) | 1992-03-17 |
| WO1992003412A2 (fr) | 1992-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW347387B (en) | Piperidine derivatives | |
| IL123585A0 (en) | Novel N-aminoalkylfluorene-carboxamides a new class of dopamine receptor subtype specific ligands | |
| AU4497293A (en) | Phenoxy- and phenoxyalkyl-piperidines as antiviral agents | |
| IL106387A (en) | Indole derivatives, their preparation and pharmaceutical compositions containing them | |
| MY117092A (en) | Chemotherapeutic pyrrolocarbazole derivatives | |
| AU6158486A (en) | Dihydro pyridine derivatives | |
| FR2702477B1 (fr) | Dérivés de benzoxazine, leur préparation et leur application en thérapeutique. | |
| EG17287A (en) | Process for preparing of tricyclic oxindole antiinflammatory agents | |
| MY131762A (en) | Pharmaceutical compounds | |
| WO1992003412A3 (fr) | Derives de benzamide | |
| DK0813411T3 (da) | Anvendelse af vincopetinderivater til hæmning af dannelse eller afsondring af amyloid -protein | |
| EP0315434A3 (fr) | Dérivés de pyridoxalhydrazones, leur préparation et leur utilisation et compositions pharmaceutiques qui les contiennent | |
| DK0788472T3 (da) | Fremgangsmåde til fremstilling af 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalenderivater | |
| EP0924204A4 (fr) | Derives du 2-phenylmorpholin-5-one et composition pharmaceutique les comprenant | |
| DK1140919T3 (da) | 1,4-Disubstituerede cyclohexanderivater til behandling af depression | |
| EP0782988A4 (fr) | Derives d'indole | |
| ES8707188A1 (es) | Procedimiento para la preparacion de compuestos de actividad antibacteriana | |
| ES2019228A6 (es) | Procedimiento de obtencion de nuevos derivados de azaspiro (4.5) decano-7, 9-diona. | |
| ES2056025A1 (es) | Nuevos derivados de indol. | |
| MX9700547A (es) | Procedimiento para la preparacion de derivados de imidazodiacepina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA CS FI HU JP KR NO PL SU US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |
|
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA CS FI HU JP KR NO PL SU US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2089151 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1991914392 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 1991914392 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1991914392 Country of ref document: EP |